The US Food and Drug Administration has approved a new antibacterial for the treatment of diarrhoea associated with Clostridium difficile in adults 18 years and older, according to the drug’s manufacturer, Optimer Pharmaceuticals Inc. ---Subscribe to MedNous to access this article--- Company News Regulation & Policy
